Keywords
Gualou Xiebai Banxia Decoction; human umbilical vein endothelial cells; activin receptor-like kinase 1; low-density lipoprotein; atherosclerosis
Abstract
Excessive low-density lipoprotein (LDL) uptake in vascular endothelial cells is closely related to atherosclerosis (AS) and coronary artery disease (CAD). Our animal study shows that Gualou Xiebai Banxia Decoction (GXBD) could reduce the amount of lipid deposition on the inner wall of blood vessels and relieve symptoms caused by AS and CAD. However, the underlying mechanism of GXBD on cells has not been elucidated yet. In this study, we study the effect of medicated serum, drawn from GXBD-intervened rats, on the human umbilical vein endothelial cells (HUVECs). Our findings suggest that GXBD-medicated rat serum can effectively reduce LDL uptake through downregulating the activin receptor-like kinase 1 (ALK1), therefore decreasing the apoptosis level of HUVECs. As a result, GXBD intervention might be an accountable approach to prevent AS-related diseases.
Citation
Shen Z, Li J, Liu M, Wang J, Dong Z, et al. (2022) Effect of Gualou Xiebai Banxia Decoction on activin receptor-like kinase 1 mediated low density lipoprotein uptake of vascular endothelial cells. SM Vasc Med 4: 9.